Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.
A thorough understanding of the relationship between viruses and hematologic cancers can help clinicians to deliver precise therapies and monitor potential complications.
Tissue biopsy is the gold standard for diagnosis in T-cell lymphoma, but is not always feasible. Could liquid biopsy be used instead, and not just for diagnosis but also for monitoring treatment response?
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
A case series of three patients suggests that obinutuzumab-induced acute thrombocytopenia is a frequent, possibly non-relapsing, and unique adverse event that deserves more attention than it currently receives.
This case highlights the need to consider whether a tumor embolism is present in the central adrenal vein, renal vein, or inferior vena cava when a diagnosis of primary adrenal lymphoma is made.
Live: Monday 10 June 2024, from 16:30 – 18:00 (CEST)
In this live interactive webinar, a multidisciplinary team of speakers will provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases.
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoid tumor, and accounts for approximately 30–40% of non-Hodgkin lymphomas. Although the prognosis has significantly improved with the advent of rituximab combination …
Aesthetic and reconstructive breast surgeries are among the most performed surgical procedures worldwide. In the USA, more than 500,000 patients are undergoing aesthetic breast surgeries annually, in which augmentation mammoplasty is the most …
Primary Sjögren’s syndrome (pSS), a chronic autoimmune condition, has been associated with an increased risk of several cancers. This study aims to delve into the relationship between pSS and the potential development of non-Hodgkin’s lymphoma …
Antibody-drug conjugates (ADCs) are a new class of monoclonal antibodies with the characteritic to specifically target tumor cells and to deliver a cytotoxic drug directly to the target cell thereby minimising side effects and improving the …
A series of patient cases underpin this live interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.
Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.
Aesthetic and reconstructive breast surgeries are among the most performed surgical procedures worldwide. In the USA, more than 500,000 patients are undergoing aesthetic breast surgeries annually, in which augmentation mammoplasty is the most …
Antibody-drug conjugates (ADCs) are a new class of monoclonal antibodies with the characteritic to specifically target tumor cells and to deliver a cytotoxic drug directly to the target cell thereby minimising side effects and improving the …
Poor literature report actual and detailed costs of chimeric antigen receptor (CAR) T-cell pathway in a real-life setting. We retrospectively collect data for all patients with relapsed/refractory aggressive large B-cell lymphoma who underwent …
Over the past years, significant strides have been made in the field of immunotherapy, revolutionizing our approach to cancer treatment. Among the remarkable advancements in this domain, the introduction of Chimeric Antigen Receptor (CAR)-T cell …
